Milrinone and Nitric Oxide: Combined Effect on Pulmonary Artery Pressures after Cardiopulmonary Bypass in Children

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 18, Issue 2, 2004, Pages 156-159

  Khazin, Vadim ^a   Kaufman, Yefim ^a   Zabeeda, Deeb ^a   Medalion, Beniamin ^a   Sasson, Lior ^a   Schachner, Arie ^a   Ezri, Tiberiu ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Cardiopulmonary bypass; Drugs; Hypertension; Milrinone; Nitric oxide; Pulmonary; Weaning

Indexed keywords

MILRINONE; NITRIC OXIDE;

ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; WEANING;

EID: 1942519330     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2004.01.020     Document Type: Article

References (11)

1. Solina A, Papp D, Ginsberg S, et al: A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. J Cardiothorac Vasc Anesth 14:12-17, 2000
2. Miller OI, Tang SF, Keech A, et al: Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: A randomised double-blind study. Lancet 356:1464-1469, 2000
3. Cohen AJ, Tamir A, Houri S, et al: Save a child's heart: we can and we should. Ann Thorac Surg 71:462-468, 2001
4. Deb B, Bradford K, Pearl RG: Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 28:795-799, 2000
5. Weinberger B, Weiss K, Heck DE, et al: Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Ther 89:67-79, 2001
6. Schulze-Neick I, Li J, Penny DJ, et al: Pulmonary vascular resistance after cardiopulmonary bypass in infants: Effect on postoperative recovery. J Thorac Cardiovasc Surg 121:1033-1039, 2001
7. Budts W, Van Pelt N, Gillyns H, et al: Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome. Heart 86:553-558, 2001
8. Patterson KW, Deb B, Kavanagh BP, et al: Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension. Pharmacology 58:246-251, 1999
9. Haraldsson SA, Kieler-Jensen N, Ricksten SE: The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth Analg 93:1439-1445, 2001
10. Kato R, Sato J, Nishino T: Milrinone decreases both pulmonary arterial and venous resistances in the hypoxic dog. Br J Anaesth 81:920-924, 1998
11. Hayward CS, Rogers P, Keogh AM, et al: Inhaled nitric oxide in cardiac failure: vascular versus ventricular effects. J Cardiovasc Pharmacol 27:80-85, 1996